Intracardiac Oximeter Market: By Type (Fiber Optic Oximeters and Wireless Oximeters), By Application (Cardiac Surgery, Intensive Care Monitoring, and Emergency Care), By End User (Hospitals, Cardiac Centers, and Ambulatory Surgical Centers), and Geography

Intracardiac Oximeter Market size was USD 427.5 million in 2023 and is expected to reach USD 747.0 million in 2030, growing at a CAGR of 8.3% during the forecast period. Intracardiac oximeters are specialized medical devices used for continuous monitoring of oxygen saturation within the heart chambers during cardiac procedures and in critical care settings. These devices offer real-time, accurate measurements of oxygen levels, which is crucial for patient management during cardiac surgeries and in intensive care units. The market is primarily driven by the increasing prevalence of cardiovascular diseases, technological advancements in oximetry, and the growing demand for minimally invasive cardiac procedures. According to the World Health Organization, cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. The market also benefits from the rising geriatric population and increasing healthcare expenditure. However, the high cost of intracardiac oximeters and the need for skilled professionals to operate these devices may pose challenges to market growth.

Intracardiac Oximeter Market Key Developments:

• In 2022, Medtronic Plc is expected to receive 510 (k) clearance from the US FDA for its Nellcor OxySoft neonatal-adult SpO2 Sensor. This sensor is a unique pulse oximeter sensor with silicone adhesive, designed to protect fragile newborn skin through longer adherence.
• In 2022, Masimo Corporation announced its limited market release of the Masimo W1 health watch, a non-invasive blood parameter monitoring solution that offers accurate, continuous measurement and actionable health insights.